787-39819-68201
2 vaccinations
2 coded responses
16 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 275 / NC
- Registered
- 2021-09-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Dose 1 — Pfizer-BioNTech
-
2021-09-04
Registered in v-safe
-
2021-09-04
Dose 2 — Pfizer-BioNTech
- 2021-09-04
-
2021-09-05
Survey response — days 1–6 daily, dose 2MedDRA: Terminal insomnia — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Early morning wakingMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-06
- 2021-09-07
- 2021-09-08
- 2021-09-09
- 2021-09-10
- 2021-09-11
- 2021-09-18
- 2021-09-25
- 2021-10-02
- 2021-10-09
- 2021-10-16
-
2021-12-04
Survey response — 3 months, dose 2MedDRA: Nasal congestion — Feeling: FairFree text: Nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-03-07
- 2022-09-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | No |
| 2 | 2021-09-04 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Early morning waking
Release 10 — 3 months, dose 2
Symptoms: Nasal congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SRO | Terminal insomnia | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release